688621 阳光诺和
已收盘 11-04 15:00:01
资讯
新帖
简况
太平洋:给予阳光诺和买入评级
证券之星 · 10-31
太平洋:给予阳光诺和买入评级
阳光诺和:10月29日接受机构调研,广发证券、国盛证券等多家机构参与
证券之星 · 10-31
阳光诺和:10月29日接受机构调研,广发证券、国盛证券等多家机构参与
开源证券:给予阳光诺和买入评级
证券之星 · 10-30
开源证券:给予阳光诺和买入评级
阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段
美港电讯 · 10-30
阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段
阳光诺和大幅上涨 获主力净流入678万元
智选洞察 · 10-30
阳光诺和大幅上涨 获主力净流入678万元
阳光诺和(688621)2024年三季报简析:营收净利润同比双双增长,应收账款上升
证券之星 · 10-30
阳光诺和(688621)2024年三季报简析:营收净利润同比双双增长,应收账款上升
阳光诺和:获得《药物临床试验批准通知书》
每日经济新闻 · 10-29
阳光诺和:获得《药物临床试验批准通知书》
阳光诺和大幅下跌 获主力净流出630万元
智选洞察 · 10-29
阳光诺和大幅下跌 获主力净流出630万元
阳光诺和(688621.SH)发布前三季度业绩 净利润2.08亿元 同比增长21.40%
智通财经 · 10-28
阳光诺和(688621.SH)发布前三季度业绩 净利润2.08亿元 同比增长21.40%
阳光诺和:业绩说明会定于12月2日举行
每日经济新闻 · 10-28
阳光诺和:业绩说明会定于12月2日举行
阳光诺和(688621)10月24日主力资金净卖出950.50万元
证券之星 · 10-25
阳光诺和(688621)10月24日主力资金净卖出950.50万元
阳光诺和10月21日主力资金流出1142万元 连续5日减仓
市场透视 · 10-21
阳光诺和10月21日主力资金流出1142万元 连续5日减仓
阳光诺和大幅上涨 获12家券商给予买入建议
智选洞察 · 10-21
阳光诺和大幅上涨 获12家券商给予买入建议
10月11日阳光诺和跌6.59%,融通健康产业灵活配置混合A/B基金重仓该股
证券之星 · 10-11
10月11日阳光诺和跌6.59%,融通健康产业灵活配置混合A/B基金重仓该股
阳光诺和大幅下跌 获主力净流出2330万元
智选洞察 · 10-11
阳光诺和大幅下跌 获主力净流出2330万元
阳光诺和:股份购买计划延期至2025年3月
美港电讯 · 10-10
阳光诺和:股份购买计划延期至2025年3月
阳光诺和:晟普医药已累计完成购买0.35%股份
格隆汇 · 10-10
阳光诺和:晟普医药已累计完成购买0.35%股份
阳光诺和创4个月新高 获融资净买入1460万元
智选洞察 · 10-08
阳光诺和创4个月新高 获融资净买入1460万元
阳光诺和(688621.SH)新增认定聂爱华为核心技术人员
智通财经 · 10-07
阳光诺和(688621.SH)新增认定聂爱华为核心技术人员
阳光诺和:核心技术人员谢道生离职
每日经济新闻 · 10-07
阳光诺和:核心技术人员谢道生离职
加载更多
公司概况
公司名称:
北京阳光诺和药物研究股份有限公司
所属行业:
研究和试验发展
上市日期:
2021-06-21
主营业务:
北京阳光诺和药物研究股份有限公司主营业务是为医药企业提供专业化研发外包服务,致力于协助中国医药制造企业加速实现进口替代和自主创新。公司的主要包括药物发现、药理药效、药学研究、临床研究和生物分析。报告期内公司参与研发和自主立项研发的项目中,共8项新药项目已通过NMPA批准进入临床试验,70项药品申报上市注册受理,8项一致性评价注册受理;取得39项药品生产注册批件;7项通过一致性评价,6项原料药通过审评获批。
发行价格:
26.89
{"stockData":{"symbol":"688621","market":"SH","secType":"STK","nameCN":"阳光诺和","latestPrice":45.46,"timestamp":1730703601000,"preClose":44.67,"halted":0,"volume":2222131,"delay":0,"floatShares":112000000,"shares":112000000,"eps":1.9766,"marketStatus":"已收盘","marketStatusCode":5,"change":0.79,"latestTime":"11-04 15:00:01","open":44.77,"high":46.26,"low":44.31,"amount":101000000,"amplitude":0.0437,"askPrice":45.47,"askSize":2,"bidPrice":45.46,"bidSize":295,"shortable":0,"etf":0,"ttmEps":1.9766,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1730770200000},"adr":0,"adjPreClose":44.67,"symbolType":"stock_kcb","openAndCloseTimeList":[[1730683800000,1730691000000],[1730696400000,1730703600000]],"highLimit":49.14,"lowLimit":40.2,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":112000000,"pbRate":4.5,"roa":"--","roe":"19.74%","epsLYR":1.65,"committee":0.926829,"marketValue":5092000000,"floatMarketCap":5092000000,"peRate":22.999089,"changeRate":0.0177,"turnoverRate":0.0198,"status":0,"afterMarket":{"amount":0,"volume":0,"close":45.46,"buyVolume":0,"sellVolume":0,"time":1730705639464,"indexStatus":"已收盘 11-04 15:30:00","preClose":44.67}},"requestUrl":"/m/hq/s/688621","defaultTab":"news","newsList":[{"id":"2479248703","title":"太平洋:给予阳光诺和买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479248703","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479248703?lang=zh_cn&edition=full","pubTime":"2024-10-31 18:21","pubTimestamp":1730370076,"startTime":"0","endTime":"0","summary":"太平洋证券股份有限公司近期对阳光诺和进行研究并发布了研究报告《Q3收入超预期,研发投入持续加大》,本报告对阳光诺和给出买入评级,当前股价为44.4元。 盈利预测与投资建议:我们预计2024年-2026年公司营收为12.42/16.37/21.43亿元,同比增长33.24%/31.83%/30.89%;归母净利为2.72/3.61/4.75亿元,同比增长47.33%/32.66%/31.68%,对应当前PE为18/14/10倍,给予“买入”评级。最新盈利预测明细如下:该股最近90天内共有6家机构给出评级,买入评级5家,增持评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100037944.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601099","688621"],"gpt_icon":0},{"id":"2479277066","title":"阳光诺和:10月29日接受机构调研,广发证券、国盛证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2479277066","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479277066?lang=zh_cn&edition=full","pubTime":"2024-10-31 17:45","pubTimestamp":1730367927,"startTime":"0","endTime":"0","summary":"证券之星消息,2024年10月31日阳光诺和发布公告称公司于2024年10月29日接受机构调研,广发证券、国盛证券、长江证券、太平洋证券、国海证券、海通证券、光大证券、华西证券、中泰证券、华安证券、华福证券、开源证券、中银证券、民生证券、国金证券、信达证券、东方证券、天风证券、方正证券、华创证券、宁银理财、德邦证券、浙商证券、兴业证券、财通证券、招商证券、中金证券、东北证券参与。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100037378.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0183","688621","BK0028","BK1147","BK0216","000776","01776","BK0188","BK1564","161027","BK0012","BK0276","SG9999001093.SGD"],"gpt_icon":0},{"id":"2479733635","title":"开源证券:给予阳光诺和买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479733635","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479733635?lang=zh_cn&edition=full","pubTime":"2024-10-30 23:43","pubTimestamp":1730303021,"startTime":"0","endTime":"0","summary":"开源证券股份有限公司余汝意,汪晋近期对阳光诺和进行研究并发布了研究报告《公司信息更新报告:单Q3营收同比快速增长,业绩表现持续亮眼》,本报告对阳光诺和给出买入评级,当前股价为44.55元。2024H1,公司取得生产批件的权益分成项目共5项,实现营业收入共333.91万元。最新盈利预测明细如下:该股最近90天内共有6家机构给出评级,买入评级5家,增持评级1家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000045248.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["161027","688621"],"gpt_icon":0},{"id":"2479184562","title":"阳光诺和和艺妙神州合作开发的CAR-T疗法获准进入系统性红斑狼疮临床试验阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2479184562","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479184562?lang=zh_cn&edition=full","pubTime":"2024-10-30 10:39","pubTimestamp":1730255969,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159938","03347","BK4077","BK1515","159837","SLE","BK1583","06978","BK1574","BK4022","09939","159992","CAR","BK1576","BK1141","688621","BK0216","BK1161","BK4230"],"gpt_icon":0},{"id":"2479792218","title":"阳光诺和大幅上涨 获主力净流入678万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479792218","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479792218?lang=zh_cn&edition=full","pubTime":"2024-10-30 10:32","pubTimestamp":1730255553,"startTime":"0","endTime":"0","summary":"10月30日,阳光诺和股价大幅上涨,截至10点32分,阳光诺和上涨5.15%,报46.53元/股,成交4980万元,换手率0.99%,振幅6.60%。资金动向截止发稿,阳光诺和获得主力净流入678万元,其中超大单流入498万元,大单流入179万元。融资融券方面,阳光诺和10月28日获得融资净买入78万元,当日该股融资余额为2.99亿元,当较前一日增加0.26%;该股融券余额为27万元,融券余量为0.59万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030103253ab809f68&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241030103253ab809f68&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0},{"id":"2479726949","title":"阳光诺和(688621)2024年三季报简析:营收净利润同比双双增长,应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2479726949","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479726949?lang=zh_cn&edition=full","pubTime":"2024-10-30 06:18","pubTimestamp":1730240329,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理,近期阳光诺和发布2024年三季报。截至本报告期末,公司营业总收入9.17亿元,同比上升32.47%,归母净利润2.08亿元,同比上升21.4%。按单季度数据看,第三季度营业总收入3.54亿元,同比上升53.2%,第三季度归母净利润5911.73万元,同比上升11.37%。本报告期阳光诺和应收账款上升,应收账款同比增幅达49.81%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000005964.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688621"],"gpt_icon":0},{"id":"2479426687","title":"阳光诺和:获得《药物临床试验批准通知书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2479426687","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479426687?lang=zh_cn&edition=full","pubTime":"2024-10-29 15:44","pubTimestamp":1730187889,"startTime":"0","endTime":"0","summary":"每经AI快讯,阳光诺和 10月29日晚间发布公告称,近日,北京阳光诺和药物研究股份有限公司与北京艺妙神州医药科技有限公司及其全资子公司厦门再妙生物科技有限公司合作研发项目“ZM001注射液”收到国家药品监督管理局核准签发的《药物临床试验批准通知书》的临床试验申请获得批准。ZM001拟用于治疗系统性红斑狼疮。截至发稿,阳光诺和市值为50亿元。道达号“个股趋势”提醒:1. 近30日内无机构对阳光诺和进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029154537a1f4849c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029154537a1f4849c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2479490926","title":"阳光诺和大幅下跌 获主力净流出630万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479490926","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479490926?lang=zh_cn&edition=full","pubTime":"2024-10-29 10:10","pubTimestamp":1730167839,"startTime":"0","endTime":"0","summary":"10月29日,阳光诺和股价大幅下跌,截至10点10分,阳光诺和下跌5.03%,报44.56元/股,成交6997万元,换手率1.37%,振幅4.90%。资金动向截止发稿,阳光诺和获得主力净流出630万元,其中超大单流出800万元,大单流入171万元。最新财报显示,今年三季报,阳光诺和实现营业收入9.17亿元,同比增长32.47%,净利润为2.08亿元,同比增长21.40%,基本每股收益为1.85元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029101059ab7d1756&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029101059ab7d1756&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2478174613","title":"阳光诺和(688621.SH)发布前三季度业绩 净利润2.08亿元 同比增长21.40%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478174613","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478174613?lang=zh_cn&edition=full","pubTime":"2024-10-28 17:33","pubTimestamp":1730108017,"startTime":"0","endTime":"0","summary":"智通财经APP讯,阳光诺和(688621.SH)披露2024年第三季度报告,该公司前三季度实现营业收入9.17亿元,同比增长32.47%。归属于上市公司股东的净利润2.08亿元,同比增长21.40%。归属于上市公司股东的扣除非经常性损益的净利润2.02亿元,同比增长20.19%。基本每股收益为1.85元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1201338.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["688621"],"gpt_icon":0},{"id":"2478643175","title":"阳光诺和:业绩说明会定于12月2日举行","url":"https://stock-news.laohu8.com/highlight/detail?id=2478643175","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478643175?lang=zh_cn&edition=full","pubTime":"2024-10-28 16:40","pubTimestamp":1730104843,"startTime":"0","endTime":"0","summary":"每经AI快讯,阳光诺和 10月28日晚间发布公告称,公司2024年第三季度业绩说明会定于2024年12月02日上午11:00-12:00,以上证路演中心网络互动的形式进行。出席本次业绩说明会的人员有:公司参加本次说明会的人员包括董事长利虔,董事、总经理刘宇晶,董事、财务总监张执交,董事会秘书魏丽萍。截至发稿,阳光诺和市值为53亿元。道达号“个股趋势”提醒:1. 近30日内无机构对阳光诺和进行调研。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028164109ab7ae0fe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028164109ab7ae0fe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0},{"id":"2478611377","title":"阳光诺和(688621)10月24日主力资金净卖出950.50万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478611377","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478611377?lang=zh_cn&edition=full","pubTime":"2024-10-25 08:20","pubTimestamp":1729815647,"startTime":"0","endTime":"0","summary":"证券之星消息,截至2024年10月24日收盘,阳光诺和报收于42.19元,下跌3.54%,换手率1.76%,成交量1.98万手,成交额8533.69万元。近5日资金流向一览见下表:阳光诺和融资融券信息显示,融资方面,当日融资买入1618.4万元,融资偿还988.86万元,融资净买入629.54万元,连续3日净买入累计1479.1万元。阳光诺和主营业务:创新药开发,仿制药开发及一致性评价等方面的综合研发服务,服务内容主要包括药物发现,药学研究,临床试验和生物分析。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102500007947.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2477088131","title":"阳光诺和10月21日主力资金流出1142万元 连续5日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2477088131","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477088131?lang=zh_cn&edition=full","pubTime":"2024-10-21 15:18","pubTimestamp":1729495117,"startTime":"0","endTime":"0","summary":"10月21日, 阳光诺和股价涨3.19%,报收42.99元,成交金额2.07亿元,换手率4.32%,振幅8.09%,量比1.86。阳光诺和今日主力资金净流出1142万元,连续5日净流出,上一交易日主力净流出1111万元,今日环比增加2.79%。近一年数据显示,该股主力连续5日净流出后,次日下跌概率为85.71%,平均跌幅为1.61%。该股近5个交易日上涨7.48%,主力资金累计净流出3499万元;近20日主力资金累计净流出8173万元,其中净流出天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410211530219f532080&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410211530219f532080&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0},{"id":"2477005614","title":"阳光诺和大幅上涨 获12家券商给予买入建议","url":"https://stock-news.laohu8.com/highlight/detail?id=2477005614","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477005614?lang=zh_cn&edition=full","pubTime":"2024-10-21 13:25","pubTimestamp":1729488359,"startTime":"0","endTime":"0","summary":"10月21日,阳光诺和股价大幅上涨,截至13点25分,阳光诺和上涨5.52%,报43.96元/股,成交1.42亿元,换手率2.99%,振幅6.79%。此外,数据统计显示,近半年内1家券商给予增持建议,12家券商给予买入建议。资金动向截止发稿,阳光诺和获得主力净流出1300万元,其中超大单流出649万元,大单流出650万元。最新财报显示,今年中报,阳光诺和实现营业收入5.63亿元,同比增长22.08%,净利润为1.49亿元,同比增长25.91%,基本每股收益为1.33元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021132609a1e22808&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241021132609a1e22808&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2474054075","title":"10月11日阳光诺和跌6.59%,融通健康产业灵活配置混合A/B基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2474054075","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474054075?lang=zh_cn&edition=full","pubTime":"2024-10-11 16:23","pubTimestamp":1728635008,"startTime":"0","endTime":"0","summary":"证券之星消息,10月11日阳光诺和跌6.59%,收盘报39.15元,换手率3.61%,成交量4.04万手,成交额1.61亿元。根据2024基金半年报公募基金重仓股数据,重仓该股的公募基金共10家,其中持有数量最多的公募基金为融通健康产业灵活配置混合A/B。融通健康产业灵活配置混合A/B的前十大重仓股如下:以上内容为证券之星据公开信息整理,由智能算法生成,不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024101100023703.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2474891038","title":"阳光诺和大幅下跌 获主力净流出2330万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2474891038","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474891038?lang=zh_cn&edition=full","pubTime":"2024-10-11 10:08","pubTimestamp":1728612502,"startTime":"0","endTime":"0","summary":"10月11日,阳光诺和股价大幅下跌,截至10点08分,阳光诺和下跌5.03%,报39.80元/股,失守40元整数关口,成交6291万元,换手率1.39%,振幅4.08%。资金动向截止发稿,阳光诺和获得主力净流出2330万元,其中超大单流出1368万元,大单流出961万元。最新财报显示,今年中报,阳光诺和实现营业收入5.63亿元,同比增长22.08%,净利润为1.49亿元,同比增长25.91%,基本每股收益为1.33元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011113745ab69502f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241011113745ab69502f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2474962437","title":"阳光诺和:股份购买计划延期至2025年3月","url":"https://stock-news.laohu8.com/highlight/detail?id=2474962437","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474962437?lang=zh_cn&edition=full","pubTime":"2024-10-10 16:52","pubTimestamp":1728550323,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159938","BK1161","BK0216","09939","BK1574","BK1515","688621"],"gpt_icon":0},{"id":"2474193796","title":"阳光诺和:晟普医药已累计完成购买0.35%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2474193796","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2474193796?lang=zh_cn&edition=full","pubTime":"2024-10-10 16:51","pubTimestamp":1728550305,"startTime":"0","endTime":"0","summary":"格隆汇10月10日丨阳光诺和公布,自2024年4月1日至2024年9月30日,晟普医药已采用集中竞价方式累计完成购买共计39.72万股,占公司总股本的0.35%,购买金额为1600.00万元,购买金额达到本次购买公司股份计划金额上限的50%。晟普医药决定将本次购买公司股份计划的履行期限延长6个月,即购买公司股份计划实施的截止日期将由原2024年9月30日延长至2025年3月31日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010165145a1dfa7f7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241010165145a1dfa7f7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","159938","688621"],"gpt_icon":0},{"id":"2473460543","title":"阳光诺和创4个月新高 获融资净买入1460万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2473460543","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473460543?lang=zh_cn&edition=full","pubTime":"2024-10-08 09:30","pubTimestamp":1728351002,"startTime":"0","endTime":"0","summary":"10月08日,阳光诺和股价大幅上涨,截至09点30分,阳光诺和上涨19.40%,报52.00元/股,创近4个月新高,突破50元整数关口,成交2073万元,换手率0.35%,振幅1.15%。资金动向截止发稿,阳光诺和获得主力净流出521万元,其中超大单流出820万元,大单流入300万元。融资融券方面,阳光诺和09月30日获得融资净买入1460万元,当日该股融资余额为3.09亿元,当较前一日增加4.96%,实现2连增;该股融券余额为18万元,融券余量为0.35万股,比上日减少73.48%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008114040a1dee4fb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241008114040a1dee4fb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0},{"id":"2473129290","title":"阳光诺和(688621.SH)新增认定聂爱华为核心技术人员","url":"https://stock-news.laohu8.com/highlight/detail?id=2473129290","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473129290?lang=zh_cn&edition=full","pubTime":"2024-10-07 16:12","pubTimestamp":1728288747,"startTime":"0","endTime":"0","summary":"智通财经APP讯,阳光诺和(688621.SH)发布公告,公司核心技术人员谢道生先生因个人原因辞去所任职务,并办理完毕相关离职手续;离职后,谢道生先生将不再担任公司及子公司任何职务。公司结合聂爱华先生的任职履历,以及未来对公司核心技术研发的参与情况与业务发展贡献等相关因素,认定其为公司核心技术人员。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1190504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0216","688621"],"gpt_icon":0},{"id":"2473596129","title":"阳光诺和:核心技术人员谢道生离职","url":"https://stock-news.laohu8.com/highlight/detail?id=2473596129","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2473596129?lang=zh_cn&edition=full","pubTime":"2024-10-07 15:50","pubTimestamp":1728287445,"startTime":"0","endTime":"0","summary":"每经AI快讯,阳光诺和 10月7日晚间发布公告称,北京阳光诺和药物研究股份有限公司核心技术人员谢道生先生因个人原因辞去所任职务,谢道生先生将不再担任公司及子公司任何职务。2024年1至6月份,阳光诺和的营业收入构成为:CRO业务占比99.98%。截至发稿,阳光诺和市值为49亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410071551579595278b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202410071551579595278b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688621","BK0216"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-06-21","address":"北京市昌平区科技园区双营西路79号院7号楼一层","stockEarnings":[{"period":"1week","weight":-0.0311},{"period":"1month","weight":0.0439},{"period":"3month","weight":0.123},{"period":"6month","weight":-0.2093},{"period":"1year","weight":-0.306},{"period":"ytd","weight":-0.3456}],"companyName":"北京阳光诺和药物研究股份有限公司","boardCode":"AI0073","perCapita":"14943股","boardName":"研究和试验发展","registeredCapital":"11200万元","compareEarnings":[{"period":"1week","weight":-0.0036},{"period":"1month","weight":-0.0079},{"period":"3month","weight":0.1545},{"period":"6month","weight":0.0581},{"period":"1year","weight":0.0922},{"period":"ytd","weight":0.1127}],"survey":" 北京阳光诺和药物研究股份有限公司主营业务是为医药企业提供专业化研发外包服务,致力于协助中国医药制造企业加速实现进口替代和自主创新。公司的主要包括药物发现、药理药效、药学研究、临床研究和生物分析。报告期内公司参与研发和自主立项研发的项目中,共8项新药项目已通过NMPA批准进入临床试验,70项药品申报上市注册受理,8项一致性评价注册受理;取得39项药品生产注册批件;7项通过一致性评价,6项原料药通过审评获批。","serverTime":1730752054658,"listedPrice":26.89,"stockholders":"7495人(较上一季度增加47.34%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"阳光诺和(688621)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供阳光诺和(688621)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"阳光诺和,688621,阳光诺和股票,阳光诺和股票老虎,阳光诺和股票老虎国际,阳光诺和行情,阳光诺和股票行情,阳光诺和股价,阳光诺和股市,阳光诺和股票价格,阳光诺和股票交易,阳光诺和股票购买,阳光诺和股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"阳光诺和(688621)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供阳光诺和(688621)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}